News & Perspective

Oct 30, 2012

Oct 30, 2012

CDC profiles wide range of global flu activities

(CIDRAP News) – An annual report released yesterday by the US Centers for Disease Control and Prevention (CDC) profiles a wide range of CDC influenza-related projects around the world, from flu surveillance in Indonesia to vaccine effectiveness studies in El Salvador and epidemiology training in Ghana.

Oct 18, 2012

Oct 18, 2012

HHS seeks comments on risks of H5N1 research

(CIDRAP News) – Federal health officials are inviting the public to weigh in on whether research on H5N1 avian influenza viruses, including strains modified in the lab to make them more transmissible, is risky enough to require new safety regulations and precautions.

Jun 22, 2012

Jun 22, 2012

CDC unveils new pandemic preparedness tools

(CIDRAP News) – The US Centers for Disease Control and Prevention (CDC) yesterday unveiled two new tools designed to boost pandemic preparedness: an inventory of H5N1 avian influenza genetic changes and a system the CDC and its partners are developing to help evaluate the threat from flu viruses circulating in animals.

Jun 21, 2012

Jun 21, 2012

DURC policy in flux in the wake of published H5N1 studies

(CIDRAP News) – Though today's publication of the second of two H5N1 transmissibility papers ends a waiting period, it doesn't halt the uncertainty over what the 8 months of controversy means for future dual-use research of concern (DURC) and the status of a voluntary moratorium.

May 30, 2012

May 30, 2012

WHO hopes for meeting on dual-use research in late fall

(CIDRAP News) – The World Health Organization (WHO) hopes to hold a meeting late this fall to discuss "dual-use" research issues raised in the controversy over publication of two studies involving lab-modified H5N1 viruses with increased transmissibility, a WHO official said today.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»